{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:26:23Z","timestamp":1759847183027,"version":"3.37.3"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"14","funder":[{"DOI":"10.13039\/501100004829","name":"Natural Science Foundation from the Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1592"],"award-info":[{"award-number":["2022NSFSC1592"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Science and Technology","doi-asserted-by":"publisher","award":["2022-YF05-01441-SN"],"award-info":[{"award-number":["2022-YF05-01441-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Medical (Youth Innovative) Scientific Research Projects","award":["Q23002","S22002","Q20013","Q20013"],"award-info":[{"award-number":["Q23002","S22002","Q20013","Q20013"]}]},{"name":"Innovation Team Project of Affiliated Hospital of Clinical School of Medicine of Chengdu University","award":["CDFYCX202207"],"award-info":[{"award-number":["CDFYCX202207"]}]},{"DOI":"10.13039\/501100013792","name":"Teaching Reform Project of Chengdu University","doi-asserted-by":"publisher","award":["cdjgb2022043","cdjgb2022166","cdjgb2019005"],"award-info":[{"award-number":["cdjgb2022043","cdjgb2022166","cdjgb2019005"]}],"id":[{"id":"10.13039\/501100013792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program of Affiliated Hospital of Chengdu University","award":["Y202204","Y202207"],"award-info":[{"award-number":["Y202204","Y202207"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Bladder cancer metastasis is an essential process in the progression of muscle-invasive\nbladder cancer. EMT plays a crucial role in facilitating the spread of cancer cells. Identifying compounds that can\ninhibit these abilities of cancer cells is a significant international endeavor.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To explore the migration and invasion effect of Moscatilin on the bladder and clarify the mechanism\nof action<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The anti-bladder cancer effect of Moscatilin was observed by a cell proliferation experiment. The migration\nand invasion of bladder cancer cells inhibited by Moscatilin were detected by Transwell and Wound healing.\nThe effects of Moscatilin on EMT-related proteins E-cadherin, N-cadherin, Snail1, Vimentin, and TGF-\u03b2\nsignaling pathways were detected by Western blot, and nucleic acid levels were verified by qPCR.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Our study revealed that Moscatilin reduced the viability of bladder cancer cells in vitro and impeded\ntheir migration and invasion in experimental settings. Furthermore, we observed that Moscatilin decreased the\nactivation levels of active proteins, specifically Smad3, Samd2, and MMP2. Additionally, we found that moscatilin\nsignificantly reduced the expression level of TGF-\u03b2 and was also capable of reversing the overexpression\neffect of TGF-\u03b2. Treatment with Moscatilin also led to significant inhibition of interstitial cell markers Ncadherin\nand Snail1, which are associated with EMT.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These findings indicate that Moscatilin impedes the migration and invasion of bladder cancer cells\nby influencing cell survival, modulating TGF-\u03b2\/Smad signaling, and inhibiting EMT.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715206307769240522075729","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T11:35:05Z","timestamp":1716982505000},"page":"1074-1084","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and\nMigration by Affecting the TGF-\u03b2 Signaling Pathway in Bladder Cancer"],"prefix":"10.2174","volume":"24","author":[{"given":"Zhihao","family":"Li","sequence":"first","affiliation":[{"name":"College of Pharmacy, Chengdu University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Long","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Long","sequence":"additional","affiliation":[{"name":"Clinical Medical College and Affiliated Hospital, Chengdu University,\nChengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"Jubber I.","year":"2023","unstructured":"Jubber I.; Ong S.; Bukavina L.; Black P.C.; Comp\u00e9rat E.; Kamat A.M.; Kiemeney L.; Lawrentschuk N.; Lerner S.P.; Meeks J.J.; Moch H.; Necchi A.; Panebianco V.; Sridhar S.S.; Znaor A.; Catto J.W.F.; Cumberbatch M.G.; Epidemiology of bladder cancer in 2023: A systematic review of risk factors. Eur Urol  2023,84(2),176-190","journal-title":"Eur Urol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"154316","DOI":"10.1016\/j.prp.2023.154316","volume":"242","author":"El-Mahdy H.A.","year":"2023","unstructured":"El-Mahdy H.A.; Elsakka E.G.E.; El-Husseiny A.A.; Ismail A.; Yehia A.M.; Abdelmaksoud N.M.; Elshimy R.A.A.; Noshy M.; Doghish A.S.; miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay \u2013 A review. Pathol Res Pract  2023,242,154316","journal-title":"Pathol Res Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"Patel V.G.","year":"2020","unstructured":"Patel V.G.; Oh W.K.; Galsky M.D.; Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin  2020,70(5),404-423","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","volume":"198","author":"Chang S.S.","year":"2017","unstructured":"Chang S.S.; Bochner B.H.; Chou R.; Dreicer R.; Kamat A.M.; Lerner S.P.; Lotan Y.; Meeks J.J.; Michalski J.M.; Morgan T.M.; Quale D.Z.; Rosenberg J.E.; Zietman A.L.; Holzbeierlein J.M.; Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline. J Urol  2017,198(3),552-559","journal-title":"J Urol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.trecan.2020.02.001","volume":"6","author":"Horn L.A.","year":"2020","unstructured":"Horn L.A.; Fousek K.; Palena C.; Tumor plasticity and resistance to immunotherapy. Trends Cancer  2020,6(5),432-441","journal-title":"Trends Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fonc.2017.00274","volume":"7","author":"Stefania D.D.","year":"2017","unstructured":"Stefania D.D.; Vergara D.; The many-faced program of epithelial\u2013mesenchymal transition: A system biology-based view. Front Oncol  2017,7,274","journal-title":"Front Oncol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trsl.2022.04.003","volume":"247","author":"Chang J.W.","year":"2022","unstructured":"Chang J.W.; Seo S.T.; Im, M.A.; Won, H.R.; Liu, L.; Oh, C.; Jin, Y.L.; Piao, Y.; Kim, H.J.; Kim, J.T.; Jung, S.N.; Koo, B.S. Claudin-1 mediates progression by regulating EMT through AMPK\/TGF-\u03b2 signaling in head and neck squamous cell carcinoma. Transl Res  2022,247,58-78","journal-title":"Transl Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Huang Y.","year":"2022","unstructured":"Huang Y.; Hong W.; Wei X.; The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol  2022,15(1),129","journal-title":"J Hematol Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Ping Q.","year":"2023","unstructured":"Ping Q.; Wang C.; Cheng X.; Zhong Y.; Yan R.; Yang M.; Shi Y.; Li X.; Li X.; Huang W.; Wang L.; Bi X.; Hu L.; Yang Y.; Wang Y.; Gong R.; Tan J.; Li R.; Li H.; Li J.; Wang W.; Li R.; TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J Transl Med  2023,21(1),475","journal-title":"J Transl Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"849938","DOI":"10.3389\/fcell.2022.849938","volume":"10","author":"Rodrigues-Junior D.M.","year":"2022","unstructured":"Rodrigues-Junior D.M.; Tsirigoti C.; Lim S.K.; Heldin C.H.; Moustakas A.; Extracellular vesicles and transforming growth factor \u03b2 signaling in cancer. Front Cell Dev Biol  2022,10,849938","journal-title":"Front Cell Dev Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2013.02.048","volume":"341","author":"Morrison C.D.","year":"2013","unstructured":"Morrison C.D.; Parvani J.G.; Schiemann W.P.; The relevance of the TGF-\u03b2 Paradox to EMT-MET programs. Cancer Lett  2013,341(1),30-40","journal-title":"Cancer Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.3390\/cancers13225724","volume":"13","author":"Benjamin D.J.","year":"2021","unstructured":"Benjamin D.J.; Lyou Y.; Advances in immunotherapy and the TGF-\u03b2 resistance pathway in metastatic bladder cancer. Cancers  2021,13(22),5724","journal-title":"Cancers"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jcm5040041","volume":"5","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Tian X.J.; Xing J.; Signal transduction pathways of EMT induced by TGF-\u03b2 SHH, and WNT and their crosstalks. J Clin Med  2016,5(4),41","journal-title":"J Clin Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","volume":"164","author":"David C.J.","year":"2016","unstructured":"David C.J.; Huang Y.H.; Chen M.; Su J.; Zou Y.; Bardeesy N.; Iacobuzio-Donahue C.A.; Massagu\u00e9 J.; TGF-\u03b2 tumor suppression through a lethal EMT. Cell  2016,164(5),1015-1030","journal-title":"Cell"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.semcancer.2023.08.002","volume":"95","author":"Kuburich N.A.","year":"2023","unstructured":"Kuburich N.A.; Sabapathy T.; Demestichas B.R.; Maddela J.J.; den Hollander P.; Mani S.A.; Proactive and reactive roles of TGF-\u03b2 in cancer. Semin Cancer Biol  2023,95,120-139","journal-title":"Semin Cancer Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Hao Y.","year":"2019","unstructured":"Hao Y.; Baker D.; ten Dijke P.; TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci  2019,20(11),2767","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"29479","DOI":"10.1038\/srep29479","volume":"6","author":"Liang Y.","year":"2016","unstructured":"Liang Y.; Zhu F.; Zhang H.; Chen D.; Zhang X.; Gao Q.; Li Y.; Conditional ablation of TGF-\u03b2 signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. Sci Rep  2016,6(1),29479","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1080\/01635581.2020.1856895","volume":"73","author":"Chestnut C.","year":"2021","unstructured":"Chestnut C.; Subramaniam D.; Dandawate P.; Padhye S.; Taylor J.; Weir S.; Anant S.; Targeting major signaling pathways of bladder cancer with phytochemicals: A review. Nutr Cancer  2021,73(11-12),2249-2271","journal-title":"Nutr Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11418-015-0931-7","volume":"70","author":"Busaranon K.","year":"2016","unstructured":"Busaranon K.; Plaimee P.; Sritularak B.; Chanvorachote P.; Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells. J Nat Med  2016,70(1),18-27","journal-title":"J Nat Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphys.2015.00154","volume":"6","author":"Karakasiliotis I.","year":"2015","unstructured":"Karakasiliotis I.; Mavromara P.; Hepatocellular carcinoma: From hepatocyte to liver cancer stem cell. Front Physiol  2015,6,154","journal-title":"Front Physiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/ijc.29134","volume":"136","author":"Faguet G.B.","year":"2015","unstructured":"Faguet G.B.; A brief history of cancer: Age-old milestones underlying our current knowledge database. Int J Cancer  2015,136(9),2022-2036","journal-title":"Int J Cancer"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1081\/CNV-120023771","volume":"21","author":"Ho C.K.","year":"2003","unstructured":"Ho C.K.; Chen C.C.; Moscatilin from the orchid Dendrobrium loddigesii is a potential anticancer agent. Cancer Invest  2003,21(5),729-736","journal-title":"Cancer Invest"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/jmf.2012.2617","volume":"16","author":"Chen C.A.","year":"2013","unstructured":"Chen C.A.; Chen C.C.; Shen C.C.; Chang H.H.; Chen Y.J.; Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells. J Med Food  2013,16(10),869-877","journal-title":"J Med Food"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00109-012-0945-5","volume":"91","author":"Pai H.C.","year":"2013","unstructured":"Pai H.C.; Chang L.H.; Peng C.Y.; Chang Y.L.; Chen C.C.; Shen C.C.; Teng C.M.; Pan S.L.; Moscatilin inhibits migration and metastasis of human breast cancer MDA-MB-231 cells through inhibition of Akt and Twist signaling pathway. J Mol Med  2013,91(3),347-356","journal-title":"J Mol Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.fct.2018.02.065","volume":"115","author":"Zhao Y.","year":"2018","unstructured":"Zhao Y.; Li Y.; Gao Y.; Yuan M.; Manthari R.K.; Wang J.; Wang J.; TGF-\u03b21 acts as mediator in fluoride-induced autophagy in the mouse osteoblast cells. Food Chem Toxicol  2018,115,26-33","journal-title":"Food Chem Toxicol"},{"key":"ref=26","first-page":"279","volume":"29","author":"Shirahata A.","year":"2009","unstructured":"Shirahata A.; Sakata M.; Sakuraba K.; Goto T.; Mizukami H.; Saito M.; Ishibashi K.; Kigawa G.; Nemoto H.; Sanada Y.; Hibi K.; Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res  2009,29(1),279-281","journal-title":"Anticancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10555-009-9194-7","volume":"28","author":"McConkey D.J.","year":"2009","unstructured":"McConkey D.J.; Choi W.; Marquis L.; Martin F.; Williams M.B.; Shah J.; Svatek R.; Das A.; Adam L.; Kamat A.; Siefker-Radtke A.; Dinney C.; Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev  2009,28(3-4),335-344","journal-title":"Cancer Metastasis Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/cancers13092032","volume":"13","author":"Wu Y.S.","year":"2021","unstructured":"Wu Y.S.; Ho J.Y.; Yu C.P.; Cho C.J.; Wu C.L.; Huang C.S.; Gao H.W.; Yu D.S.; Ellagic acid resensitizes gemcitabine-resistant bladder cancer cells by inhibiting epithelial-mesenchymal transition and gemcitabine transporters. Cancers  2021,13(9),2032","journal-title":"Cancers"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","volume":"72","year":"2023","unstructured":"Semeniuk-Wojta\u015b A.; Podd\u0119bniak-Strama, K.; Modzelewska, M.; Bary\u0142a, M.; Dzi\u0105g-Dudek, E.; Syry\u0142o, T.; G\u00f3rnicka, B.; Jakie\u0142a, A.; Stec, R. Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer. Cancer Immunol Immunother  2023,72(7),1971-1989","journal-title":"Cancer Immunol Immunother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.2147\/CMAR.S177373","volume":"10","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Zhang P.; Shao M.; Zang X.; Zhang J.; Mao F.; Qian H.; Xu W.; SALL4 activates TGF-\u03b2\/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis. Cancer Manag Res  2018,10,4459-4470","journal-title":"Cancer Manag Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.7150\/jca.29205","volume":"10","author":"Chen W.","year":"2019","unstructured":"Chen W.; Jiang T.; Mao H.; Gao R.; Gao X.; He Y.; Zhang H.; Chen Q.; Nodal promotes the migration and invasion of bladder cancer cells via regulation of snail. J Cancer  2019,10(6),1511-1519","journal-title":"J Cancer"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e2508","DOI":"10.1038\/cddis.2016.405","volume":"7","author":"Chen X.","year":"2016","unstructured":"Chen X.; Cao X.; Sun X.; Lei R.; Chen P.; Zhao Y.; Jiang Y.; Yin J.; Chen R.; Ye D.; Wang Q.; Liu Z.; Liu S.; Cheng C.; Mao J.; Hou Y.; Wang M.; Siebenlist U.; Eugene Chin Y.; Wang Y.; Cao L.; Hu G.; Zhang X.; Bcl-3 regulates TGF\u03b2 signaling by stabilizing Smad3 during breast cancer pulmonary metastasis. Cell Death Dis  2016,7(12),e2508","journal-title":"Cell Death Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"Cano A.","year":"2000","unstructured":"Cano A.; P\u00e9rez-Moreno M.A.; Rodrigo I.; Locascio A.; Blanco M.J.; del Barrio M.G.; Portillo F.; Nieto M.A.; The transcription factor Snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol  2000,2(2),76-83","journal-title":"Nat Cell Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4161\/cam.5.4.17290","volume":"5","author":"Serrels A.","year":"2011","unstructured":"Serrels A.; Canel M.; Brunton V.G.; Frame M.C.; Src\/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement. Cell Adhes Migr  2011,5(4),360-365","journal-title":"Cell Adhes Migr"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ncb758","volume":"4","author":"Fujita Y.","year":"2002","unstructured":"Fujita Y.; Krause G.; Scheffner M.; Zechner D.; Leddy H.E.M.; Behrens J.; Sommer T.; Birchmeier W.; Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol  2002,4(3),222-231","journal-title":"Nat Cell Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1242\/jcs.072165","volume":"124","author":"Guadamillas M.C.","year":"2011","unstructured":"Guadamillas M.C.; Cerezo A.; del Pozo M.A.; Overcoming anoikis \u2013 pathways to anchorage-independent growth in cancer. J Cell Sci  2011,124(19),3189-3197","journal-title":"J Cell Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2005420","DOI":"10.1080\/21688370.2021.2005420","volume":"10","author":"Rubtsova S.N.","year":"2022","unstructured":"Rubtsova S.N.; Zhitnyak I.Y.; Gloushankova N.A.; Dual role of E-cadherin in cancer cells. Tissue Barriers  2022,10(4),2005420","journal-title":"Tissue Barriers"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"a029199","DOI":"10.1101\/cshperspect.a029199","volume":"9","author":"Friedl P.","year":"2017","unstructured":"Friedl P.; Mayor R.; Tuning collective cell migration by cell\u2013cell junction regulation. Cold Spring Harb Perspect Biol  2017,9(4),a029199","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s12253-019-00731-z","volume":"26","author":"Wangmo C.","year":"2020","unstructured":"Wangmo C.; Charoen N.; Jantharapattana K.; Dechaphunkul A.; Thongsuksai P.; Epithelial\u2013mesenchymal transition predicts survival in oral squamous cell carcinoma. Pathol Oncol Res  2020,26(3),1511-1518","journal-title":"Pathol Oncol Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"Mendez M.G.","year":"2010","unstructured":"Mendez M.G.; Kojima S.I.; Goldman R.D.; Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J  2010,24(6),1838-1851","journal-title":"FASEB J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/onc.2010.421","volume":"30","author":"Zhu Q-S.","year":"2011","unstructured":"Zhu Q-S.; Rosenblatt K.; Huang K-L.; Lahat G.; Brobey R.; Bolshakov S.; Nguyen T.; Ding Z.; Belousov R.; Bill K.; Luo X.; Lazar A.; Dicker A.; Mills G.B.; Hung M-C.; Lev D.; Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene  2011,30(4),457-470","journal-title":"Oncogene"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1096\/fj.201700663R","volume":"32","author":"Trogden K.P.","year":"2018","unstructured":"Trogden K.P.; Battaglia R.A.; Kabiraj P.; Madden V.J.; Herrmann H.; Snider N.T.; An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells. FASEB J  2018,32(5),2841-2854","journal-title":"FASEB J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"Kaufhold S.","year":"2014","unstructured":"Kaufhold S.; Bonavida B.; Central role of Snail1 in the regulation of EMT and resistance in cancer: A target for therapeutic intervention. J Exp Clin Cancer Res  2014,33(1),62","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.3390\/ijms241914815","volume":"24","author":"Lu J.","year":"2023","unstructured":"Lu J.; Kornmann M.; Traub B.; Role of epithelial to mesenchymal transition in colorectal cancer. Int J Mol Sci  2023,24(19),14815","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/abbs\/gmx117","volume":"50","author":"Song J.","year":"2018","unstructured":"Song J.; Shi W.; The concomitant apoptosis and EMT underlie the fundamental functions of TGF-\u03b2. Acta Biochim Biophys Sin  2018,50(1),91-97","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/cells12030416","volume":"12","author":"Ray I.","year":"2023","unstructured":"Ray I.; Michael A.; Meira L.B.; Ellis P.E.; The role of cytokines in epithelial\u2013mesenchymal transition in gynaecological cancers: A systematic review. Cells  2023,12(3),416","journal-title":"Cells"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11523-015-0386-5","volume":"11","author":"Islam S.S.","year":"2016","unstructured":"Islam S.S.; Mokhtari R.B.; Akbari P.; Hatina J.; Yeger H.; Farhat W.A.; Simultaneous targeting of bladder tumor growth, survival, and epithelial-to-mesenchymal transition with a novel therapeutic combination of acetazolamide (AZ) and sulforaphane (SFN). Target Oncol  2016,11(2),209-227","journal-title":"Target Oncol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","volume":"69","author":"Oh S.H.","year":"2018","unstructured":"Oh S.H.; Swiderska-Syn M.; Jewell M.L.; Premont R.T.; Diehl A.M.; Liver regeneration requires Yap1-TGF\u03b2-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol  2018,69(2),359-367","journal-title":"J Hepatol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.stem.2019.03.010","volume":"24","author":"Wei X.","year":"2019","unstructured":"Wei X.; Zhang L.; Zhou Z.; Kwon O.J.; Zhang Y.; Nguyen H.; Dumpit R.; True L.; Nelson P.; Dong B.; Xue W.; Birchmeier W.; Taketo M.M.; Xu F.; Creighton C.J.; Ittmann M.M.; Xin L.; Spatially restricted stromal wnt signaling restrains prostate epithelial progenitor growth through direct and indirect mechanisms. Cell Stem Cell  2019,24(5),753-768.e6","journal-title":"Cell Stem Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"Wang X.","year":"2023","unstructured":"Wang X.; Eichhorn P.J.A.; Thiery J.P.; TGF-\u03b2, EMT, and resistance to anti-cancer treatment. Semin Cancer Biol  2023,97,1-11","journal-title":"Semin Cancer Biol"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206307769240522075729","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230403\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206307769240522075729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:49:09Z","timestamp":1727084949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230403\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206307769240522075729","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}